4.7 Article

Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma

Jiyan Wang et al.

Summary: Tyrosine is an essential amino acid involved in the metabolism of proteins, lipids, and carbohydrates. Down-regulation of tyrosine-metabolizing enzymes in hepatocellular carcinoma (HCC) is associated with a poor prognosis. Reduced tyrosine metabolism activates the cell cycle and promotes cell proliferation.

BIOMEDICINES (2022)

Article Medicine, General & Internal

Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes

Michael Staehler et al.

Summary: This study compared the outcomes of patients who received single fraction RRS with those who underwent open partial nephrectomy (OPN). The results showed that RRS is a viable alternative to OPN in patients unfit for surgery, with comparable oncological and functional outcomes.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Endocrinology & Metabolism

Metabolomic and elemental profiling of human tissue in kidney cancer

Joanna Niziol et al.

Summary: This study aimed to perform metabolomic and elemental profiling of human kidney cancer and normal tissue in order to evaluate cancer biomarkers. The results identified five potential tissue biomarkers of kidney cancer and suggested their potential for clinical prognosis and diagnosis.

METABOLOMICS (2021)

Article Cell Biology

GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis

Qiujie Wang et al.

Summary: The study revealed that GSTZ1 enhances sorafenib-induced ferroptosis by inhibiting the NRF2/GPX4 axis in HCC cells, and the combination therapy of sorafenib and GPX4 inhibitor RSL3 may be a promising strategy in HCC treatment.

CELL DEATH & DISEASE (2021)

Article Biochemistry & Molecular Biology

GSTZ1-1 downregulates Wnt/β-catenin signalling in hepatocellular carcinoma cells

Chong Lei et al.

FEBS OPEN BIO (2020)

Review Oncology

The Metabolic Basis of Kidney Cancer

W. Marston Linehan et al.

CANCER DISCOVERY (2019)

Article Oncology

GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway

Jingjing Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Medicine, General & Internal

Renal cell carcinoma

James J. Hsieh et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Oncology

An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

A. Ari Hakimi et al.

CANCER CELL (2016)

Article Genetics & Heredity

First report of HGD mutations in a Chinese with alkaptonuria

Yong-jia Yang et al.

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Editorial Material Biochemical Research Methods

Linkage of microRNA and Proteome-Based Profiling Data Sets: A Perspective for the Priorization of Candidate Biomarkers in Renal Cell Carcinoma?

Barbara Seliger et al.

JOURNAL OF PROTEOME RESEARCH (2011)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Review Medicine, General & Internal

von Hippel-Lindau disease

RR Lonser et al.

LANCET (2003)